Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression

Current Medical Research and Opinion

Volumn 21, Issue 9, 2005, Pages 1369-1375

  Lee, Min Soo ^a   Ham, Byung Joo ^b   Kee, Baik Seok ^c   Kim, Jung Bum ^d   Yeon, Byeong Kil ^b   Oh, Kang Seob ^e   Oh, Byoung Hoon ^f   Lee, Chul ^g   Jung, Han Yong ^h   Chee, Ik Seung ⁱ   Choe, Byeong Moo ^j   Paik, In Ho ^g  

^a Korea University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Chung Ang University   (South Korea)

^d Keimyung University   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Yonsei University   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Soonchunhyang University   (South Korea)

ⁱ Chungnam National University   (South Korea)

^j Dong A University College of Medicine   (South Korea)

more..

Author keywords

Antidepressant efficacy; Fluoxetine; Korean ptients; Milnacipran; Safety

Indexed keywords

FLUOXETINE; MILNACIPRAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL DISEASE; HAMILTON SCALE; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; INSOMNIA; KOREA; LIVER FAILURE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NAUSEA; ORTHOSTATIC HYPOTENSION; RANDOMIZED CONTROLLED TRIAL; SEROTONIN SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CYCLOPROPANES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; HUMANS; KOREA; MALE; MIDDLE AGED; SAFETY; TREATMENT OUTCOME;

EID: 25444432307     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X59166     Document Type: Article

References (19)

1. Klerman GL, Weissman MM. Increasing rates of depression. JAMA 1989;261:2229-35
2. Chiu E. Epidemiology of depression in the Asia Pacific region. Australas Psychiatry 2004;12(Suppl):S4-10
3. Jang Y, Small BJ, Haley WE. Cross-cultural comparability of the Geriatric Depression Scale: comparison between older Koreans and older Americans. Aging Ment Health 2001;5:31-7
4. Preskorn SH. Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor. J Psychiatr Pract 2004;10:119-26
5. Boyer P, Briley M. Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor. Drugs Today (Barc) 1998;34:709-20
6. Puech A, Montgomery SA, Prost JF, Solles A, Briley M. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int Clin Psychopharmacol 1997;12:99-108
7. Tajima O. Japanese experience with dual-action antidepressants. Int Clin Psychopharmacol 2002;17(Suppl 1):S37-42
8. Kasper S, Pletan Y, Solles A, Tournoux A. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. Int Clin Psychopharmacol 1996;11(Suppl 4):35-9
9. Puozzo C, Leonard BE. Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol 1996;11(Suppl 4):15-27
10. Sawada Y, Ohtani H. Pharmacokinetics and drug interactions of antidepressive agents. Nippon Rinsho 2001;59:1539-45
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;12:56-62
12. Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9
13. Guy W (Ed). ECDEU Assessment Manual for Psychopharmacology (revised). Rockville, MD. National Institute for Mental Health, Psychopharmacology Research Branch, 1976
14. Covi L, Lipman RS, McNair DM, Czerlinsky T. Symptomatic volunteers in multicenter drug trials. Prog Neuropsychopharmacol 1979;3:521-33
15. Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001;57:161-78
16. Thase ME. Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry 2003;64(Suppl 2):3-7
17. Guelfi JD, Ansseau M, Corruble E, Samuelian JC, Tonelli I, Tournoux A, Pletan Y. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. Int Clin Psychopharmacol 1998;13:121-8
18. Clerc G, Milnacipran/Fluvoxamine Study Group. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. Int Clin Psychopharmacol 2001;16:145-51
19. Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF. Milnacipran and selective serotonin reuptake inhibitors in major depression. Int Clin Psychopharmacol 1996;1(Suppl 4):41-6